SCHEMBL6021869

SCHEMBL6021869

CCCc1cccc(OC2CCN(S(=O)(=O)c3ccc(CNC(=O)c4cccc([N+](=O)[O-])c4)s3)CC2)c1.O=C(NCc1ccc(S(=O)(=O)N2CCC(Nc3cccc(S(=O)(=O)N4CCOCC4)c3)CC2)s1)c1cccc([N+](=O)[O-])c1

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 3/20 0.42
KMT2A Q03164 4/20 0.41
MEN1 O00255 3/20 0.41
ALDH1A1 P00352 4/20 0.40
MAPT P10636 3/20 0.40
GAA P10253 3/20 0.40
LMNA P02545 3/20 0.39
ALB P02768 1/20 0.39
POLB P06746 1/20 0.39
HPGD P15428 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
HSD17B10 Q99714 1/20 0.39
NPC1 O15118 1/20 0.38
APOBEC3A P31941 1/20 0.38
APOBEC3G Q9HC16 1/20 0.38
SIRT2 Q8IXJ6 1/20 0.38
THRB P10828 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7443445 0.91 ALDH1A1 (0.46) MAPK1KMT2AMEN1ALDH1A1MAPT
SCHEMBL2421323 0.89 KMT2A (0.50) MAPK1KMT2AMEN1ALDH1A1LMNA
SCHEMBL2419841 0.89 MAPK1 (0.49) MAPK1KMT2AMEN1ALDH1A1MAPT
SCHEMBL4197508 0.88 MAPT (0.34) MAPK1KMT2AMEN1ALDH1A1MAPT
SCHEMBL2419313 0.87 MEN1 (0.49) MAPK1KMT2AMEN1ALDH1A1MAPT
SCHEMBL7437261 0.85 MEN1 (0.43) KMT2AMEN1ALDH1A1MAPTGAA
SCHEMBL2425264 0.83 MEN1 (0.51) KMT2AMEN1ALDH1A1MAPTGAA
SCHEMBL4965488 0.83 MEN1 (0.42) KMT2AMEN1ALDH1A1GAASMN1; SMN2
SCHEMBL2425351 0.83 MEN1 (0.49) MAPK1KMT2AMEN1ALDH1A1MAPT
SCHEMBL3480013 0.83 MAPT (0.50) MAPK1KMT2AMEN1ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1663193-A1 SULFONAMIDE DERIVATIVES FOR THE TREATMENT OF DIABETES Applied Research Systems ARS Holding N.V. (AN) 2006-06-07 EP claimed
WO-2005025558-A1 SULFONAMIDE DERIVATIVES FOR THE TREATMENT OF DIABETES APPLIED RESERACH SYSTEMS ARS HOLDING N.V. (AN) 2005-03-24 WO claimed